Literature DB >> 1505071

Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.

M A Alaoui-Jamali1, L Panasci, G M Centurioni, R Schecter, S Lehnert, G Batist.   

Abstract

We examined the relationship between intracellular levels of glutathione (GSH), glutathione-S-transferase (GST) activity, and the kinetics of DNA cross-links induced by the bifunctional alkylating drugs melphalan (MLN), chlorambucil (CLB), and mechlorethamine (HN2) in a rat mammary carcinoma cell line (WT) and in a subline selected in vitro for primary resistance to MLN (MLNr, 16-fold resistance). MLNr cells exhibit a 2-fold increase in intracellular GSH concentration and an approximately 5-fold increase in GST activity as compared with the parent cells. They are cross-resistant to a variety of drugs, including CLB (6-fold) and HN2 (14-fold). Treatment of WT cells with 30 microM MLN or CLB induced a significant accumulation of DNA-DNA cross-links for up to 8 h, which decreased over a 24-h period. In MLNr cells, no significant cross-link formation was induced by either MLN of CLB at any time between 0 and 24 h. Doses of up to 100 microM MLN failed to induce cross-links in MLNr cells. Formation of cross-links was observed immediately after treatment with HN2 in both cell lines and was followed by a subsequent decrease during a 24-h incubation in drug-free medium. At an equimolar concentration (30 microM), the numbers of HN2-induced cross-links were significantly lower in MLNr cells than in WT cells. However, treatment of MLNr cells with 60 microM HN2 resulted in cross-link levels similar to those obtained using 30 microM HN2 in WT cells. The 35% decrease in MLN accumulation observed in MLNr cells could not entirely explain the absence of cross-links, since thin-layer chromatographic analysis demonstrated that both cell lines accumulate a significant amount of MLN and metabolize it to the same extent. Significant amounts of MLN were also detected in nuclei isolated from WT and MLNr cells that had been treated with 30 microM [14C]-MLN. Intracellular depletion of GSH by a nontoxic concentration of L-buthionine-(S, R)-sulfoximine (BSO, 100 microM; about 70% GSH depletion) significantly sensitized MLNr cells to MLN and increased cross-link formation. A nontoxic concentration (50 microM) of ethacrynic acid (EA, an inhibitor of GST showing some specificity for Yc/Yp subunits) also sensitized MLNr cells to MLN and increased cross-link formation. Our data demonstrate that both EA and BSO are effective modulators of nitrogen mustard cytotoxicity in tumor cells resistant to alkylating drugs.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505071     DOI: 10.1007/bf00689960

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  37 in total

1.  Compartmentalised depletion of glutathione in cells treated with buthionine sulphoximine.

Authors:  M Edgren; L Révész
Journal:  Br J Radiol       Date:  1987-07       Impact factor: 3.039

2.  Interaction of platinum compounds with dinucleotides.

Authors:  I A Roos; A J Thomson; S Mansy
Journal:  J Am Chem Soc       Date:  1974-10-02       Impact factor: 15.419

3.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

4.  Formation of blocking lesions at identical DNA sequences by the nitrosourea and platinum classes of anticancer drugs.

Authors:  J D Gralla; S Sasse-Dwight; L G Poljak
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

5.  Lack of drug-induced DNA cross-links in chlorambucil-resistant Chinese hamster ovary cells.

Authors:  B Z Jiang; B B Bank; Y H Hsiang; T Shen; M Potmesil; R Silber
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

6.  Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.

Authors:  R J Fram; B A Woda; J M Wilson; N Robichaud
Journal:  Cancer Res       Date:  1990-01-01       Impact factor: 12.701

7.  Repair of chromatin damage in glutathione-depleted V-79 cells: comparison of oxic and hypoxic conditions.

Authors:  L Y Xue; L R Friedman; N L Oleinick
Journal:  Radiat Res       Date:  1988-10       Impact factor: 2.841

8.  Differential inhibition of rat and human glutathione S-transferase isoenzymes by plant phenols.

Authors:  M Das; S V Singh; H Mukhtar; Y C Awasthi
Journal:  Biochem Biophys Res Commun       Date:  1986-12-30       Impact factor: 3.575

9.  Inhibition of purified rat liver glutathione S-transferase isozymes by diuretic drugs.

Authors:  J T Ahokas; F A Nicholls; P J Ravenscroft; B T Emmerson
Journal:  Biochem Pharmacol       Date:  1985-06-15       Impact factor: 5.858

10.  Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines.

Authors:  K D Tew; A M Bomber; S J Hoffman
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

View more
  4 in total

Review 1.  Isolated limb infusion as a model to test new agents to treat metastatic melanoma.

Authors:  Michael E Lidsky; Paul J Speicher; Betty Jiang; Masahito Tsutsui; Douglas S Tyler
Journal:  J Surg Oncol       Date:  2013-11-20       Impact factor: 3.454

2.  Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs.

Authors:  M Alaoui-Jamali; B B Loubaba; S Robyn; H Tapiero; G Batist
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Lack of cross-resistance to a new cytotoxic arylchloroethyl urea in various drug-resistant tumor cells.

Authors:  R C Gaudreault; M A Alaui-Jamali; G Batist; P Béchard; J Lacroix; P Poyet
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT).

Authors:  N R Monks; J A Calvete; N J Curtin; D C Blakey; S J East; D R Newell
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.